|
|
| MRD / Regn No. |
: THBC\23-24\04299 |
Date |
: 11/06/2026 |
| Patient Name |
: Vimla Bohra |
Age & Gender |
: 58 Yrs. / Female |
| Contact No. |
: 9867285284 |
UHID |
: |
| Ht / Wt / BMI |
: 162.6 / 90 / 34.04 |
BP S / BP D |
: 118 / 79 |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (22/May/2021) | HTN (22/May/2014) | DYSLIPIDEMIA (22/May/2014) | |
|
Subjective |
: |
T2DM SINCE 2012,HTN/DYSLIPIDEMIA 2014,TINEA RESOLVED - FRICTIONAL DERMATITIS,UTI DUE TO DAPAGLIFLOZIN |
|
Objective |
: |
09-JUN-2026 REPORTS,HB-11.5/ HBA1C-8.7%,FBS-91,TC-160/ TG-192/ LDL-88/ HDL-34,ALT-21/ AST-17,CR-0.61,HSCRP-5.93,C-REACTIVE PROTEIN - 6.30,T3-1.19/ T4-7.2/ TSH-2.859,FT3-2.96/ FT4-1.17,VITD-63,VITB12-559,FSH-18.4/ LH-7.22,PRL-4.59 |
|
Plan |
: |
SUNDAE 0.25 MG WEEKLY X 4 WEEKS,IF TOLERATES WELL - 0.5 MG WEEKLY FOR THE NEXT WEEK,3RD MTH - 1 MG WEEKLY |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
GLARITUS |
ORAL |
0-0-24 |
11 PM BEDTIME
|
4 MTHS |
|
|
2 |
TABLET CILNIDIPINE(10MG) + TELMISARTAN(40MG)
TELMA LN 40+10 |
ORAL |
1-0-0 |
ABF
|
3 MTHS |
|
|
3 |
ROSUCOR F |
ORAL |
0-0-1 |
TAKES ALT DAY
|
3 MTHS |
|
|
4 |
PREGEB NT |
ORAL |
0-0-1 |
6-7 PM
|
3 MTHS |
|
|
5 |
DRISE 60,000 UNITS |
ORAL |
ONCE IN A WEEK |
ANYTIME OF DAY
|
3 MTHS |
|
|
6 |
TABLET GLIMEPIRIDE (2MG)+ METFORMIN(500)+ VOGLIBOSE(0.2)
GLYCOMET TRIO 2 |
ORAL |
1-0-1 |
BBF/BD
|
3 MTHS |
|
|
7 |
NERVIHENZ |
ORAL |
0-1-0 |
ALT DAY
|
3 MTHS |
|
|
8 |
SITABITE M 100/500 |
ORAL |
1-0-0 |
ABF
|
3 MTHS |
|
|
9 |
SUNDAE 0.25 MG |
SC |
1/WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 11/Sep/2026 |
| Tests Suggested For Next Visit |
: FBS / PPBS / HBA1C > 3 MTHS,IF SEMAGLUTIDE DOES NOT SUIT HER - THEN CAN SWITCH TO RYZODEG |
| |
|
| |
|
|
